Blockade of glucagon-like peptide 1 receptor corrects postprandial hypoglycemia after gastric bypass.

BACKGROUND & AIMS Postprandial glycemia excursions increase after gastric bypass surgery; this effect is even greater among patients with recurrent hypoglycemia. These patients also have increased postprandial levels of insulin and glucagon-like peptide 1 (GLP-1). We performed a clinical trial to determine the role of GLP-1 in postprandial glycemia in patients with hyperinsulinemic hypoglycemia syndrome after gastric bypass. METHODS Nine patients with recurrent hypoglycemia after gastric bypass (H-GB), 7 patients who were asymptomatic after gastric bypass (A-GB), and 8 healthy control subjects underwent a mixed-meal tolerance test (350 kcal) using a dual glucose tracer method on 2 separate days. On 1 day they received continuous infusion of the GLP-1 receptor antagonist exendin (9-39) (Ex-9), and on the other day they received a saline control. Glucose kinetics and islet and gut hormone responses were measured before and after the meal. RESULTS Infusion of Ex-9 corrected hypoglycemia in all patients with H-GB. The reduction in postprandial insulin secretion by Ex-9 was greater in the H-GB group than in the other groups (H-GB, 50% ± 8%; A-GB, 13% ± 10%; controls, 14% ± 10%) (P < .05). The meal-derived glucose appearance was significantly greater in subjects who had undergone gastric bypass compared to the controls and in the H-GB group compared to the A-GB group. Ex-9 shortened the time to reach peak meal-derived glucose appearance in all groups without a significant effect on overall glucose flux. Postprandial glucagon levels were higher among patients who had undergone gastric bypass than controls and increased with administration of Ex-9. CONCLUSIONS Hypoglycemia after gastric bypass can be corrected by administration of a GLP-1 receptor antagonist, which might be used to treat this disorder. These findings are consistent with reports that increased GLP-1 activity contributes to hypoglycemia after gastric bypass. ClinicalTrials.gov, Number: NCT01803451.

[1]  A. Gastaldelli,et al.  The effect of chronic twice daily exenatide treatment on β‐cell function in new onset type 2 diabetes , 2014, Clinical endocrinology.

[2]  Amalia Gastaldelli,et al.  Eight weeks of treatment with long-acting GLP-1 analog taspoglutide improves postprandial insulin secretion and sensitivity in metformin-treated patients with type 2 diabetes. , 2013, Metabolism: clinical and experimental.

[3]  J. Holst,et al.  Exaggerated Glucagon-Like Peptide 1 Response Is Important for Improved β-Cell Function and Glucose Tolerance After Roux-en-Y Gastric Bypass in Patients With Type 2 Diabetes , 2013, Diabetes.

[4]  J. Holst,et al.  Effects of gastric bypass surgery on glucose absorption and metabolism during a mixed meal in glucose-tolerant individuals , 2013, Diabetologia.

[5]  S. Madsbad,et al.  Fast pouch emptying, delayed small intestinal transit, and exaggerated gut hormone responses after Roux‐en‐Y gastric bypass , 2013, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[6]  J. Holst,et al.  Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance. , 2012, American journal of physiology. Endocrinology and metabolism.

[7]  A. Cherrington,et al.  Regulation of hepatic glucose uptake and storage in vivo. , 2012, Advances in nutrition.

[8]  D. D’Alessio,et al.  Gastric Bypass Surgery Enhances Glucagon-Like Peptide 1–Stimulated Postprandial Insulin Secretion in Humans , 2011, Diabetes.

[9]  A. Mari,et al.  Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes , 2011, Diabetologia.

[10]  J. Holst,et al.  Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides. , 2011, The Journal of clinical endocrinology and metabolism.

[11]  D. D’Alessio,et al.  Effect of Endogenous GLP-1 on Insulin Secretion in Type 2 Diabetes , 2010, Diabetes.

[12]  P. Cryer,et al.  Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. , 2009, The Journal of clinical endocrinology and metabolism.

[13]  D. D’Alessio,et al.  Regulation of islet hormone release and gastric emptying by endogenous glucagon-like peptide 1 after glucose ingestion. , 2008, The Journal of clinical endocrinology and metabolism.

[14]  J. Teixeira,et al.  Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. , 2008, The Journal of clinical endocrinology and metabolism.

[15]  M. Suter,et al.  Effects of Gastric Bypass and Gastric Banding on Glucose Kinetics and Gut Hormone Release , 2008, Obesity.

[16]  Daniel B. Jones,et al.  Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. , 2007, The Journal of clinical endocrinology and metabolism.

[17]  E. Ferrannini,et al.  Effect of Pioglitazone on the Metabolic and Hormonal Response to a Mixed Meal in Type II Diabetes , 2007, Clinical pharmacology and therapeutics.

[18]  Claudio Cobelli,et al.  Assessment of postprandial glucose metabolism: conventional dual- vs. triple-tracer method. , 2006, American journal of physiology. Endocrinology and metabolism.

[19]  E. Ferrannini,et al.  Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function , 2006, Diabetologia.

[20]  P. Butler,et al.  Hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased beta-cell turnover. , 2006, Diabetes care.

[21]  Josep Vidal,et al.  Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects. , 2006, The Journal of clinical endocrinology and metabolism.

[22]  P. Butler,et al.  Comment to: Patti ME, Mcmahon G, Mun EC et al. (2005) Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia 48:2236–2240 , 2006, Diabetologia.

[23]  J. Holst,et al.  Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia , 2005, Diabetologia.

[24]  Michael Horowitz,et al.  Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects. , 2005, American journal of physiology. Endocrinology and metabolism.

[25]  R. Lloyd,et al.  Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. , 2005, The New England journal of medicine.

[26]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[27]  Andrea Mari,et al.  Meal and oral glucose tests for assessment of beta -cell function: modeling analysis in normal subjects. , 2002, American journal of physiology. Endocrinology and metabolism.

[28]  B. Göke,et al.  Gastric emptying and release of incretin hormones after glucose ingestion in humans. , 1996, The Journal of clinical investigation.

[29]  Jeppe Sturis,et al.  Estimation of Insulin Secretion Rates from C-Peptide Levels: Comparison of Individual and Standard Kinetic Parameters for C-Peptide Clearance , 1992, Diabetes.

[30]  B H Frank,et al.  Dose-dependent effects of oral and intravenous glucose on insulin secretion and clearance in normal humans. , 1988, The American journal of physiology.

[31]  R. Rizza,et al.  Incretin Effect Due to Increased Secretion and Decreased Clearance of Insulin in Normal Humans , 1988, Diabetes.

[32]  M. Horowitz,et al.  Gastric emptying after gastric bypass. , 1986, International journal of obesity.

[33]  M. Horowitz,et al.  Measurement of gastric emptying after gastric bypass surgery using radionuclides , 1982, The British journal of surgery.

[34]  H. Sigstad.  A clinical diagnostic index in the diagnosis of the dumping syndrome. Changes in plasma volume and blood sugar after a test meal. , 2009, Acta medica Scandinavica.

[35]  R. Steele,et al.  Glucose Uptake and Production During the Oral Glucose Tolerance Test , 1968, Diabetes.

[36]  R. Steele,et al.  INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT * , 1959, Annals of the New York Academy of Sciences.